2566 — Hangzhou Jiuyuan Genetic Biopharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.05bn
- HK$2.51bn
- CNY1.37bn
- 75
- 38
- 35
- 48
Annual cashflow statement for Hangzhou Jiuyuan Genetic Biopharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 128 | 51.4 | 135 | 169 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 10.9 | 11.2 | 23.6 | 26.2 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -95.2 | -75.8 | -58.9 | -137 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 67.5 | 22.6 | 136 | 94.8 |
| Capital Expenditures | -62.9 | -59 | -47 | -79.8 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 0.048 | 0.011 | 0.002 | 0.119 |
| Sale of Fixed Assets | ||||
| Cash from Investing Activities | -62.9 | -58.9 | -47 | -79.7 |
| Financing Cash Flow Items | -9.74 | -21 | -14.5 | -46.3 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 41.2 | 12.9 | -67.3 | 428 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 45.8 | -23.3 | 21.6 | 444 |